Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Quince Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +4 vs. Q2 2025
- Shares held
- 11.8M
- +4.21M (+55.6%) vs. Q2 2025
- Total value
- $19.2M
- +$6.72M (+53.7%) vs. Q2 2025
- New holders
- 8
- 13 more added
- Sold out
- 4
- 9 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $4.74M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 3,073,729 | $5.01M | 0.31% | +545,427+21.6% | Added |
| Vanguard Group Inc | 1,763,387 | $2.87M | 0.00% | +309,349+21.3% | Added |
| Millennium Management LLC | 1,386,776 | $2.26M | 0.00% | +1,276,094+1,152.9% | Added |
| Ieq Capital, LLC | 981,264 | $1.60M | 0.00% | +541,994+123.4% | Added |
| ADAR1 Capital Management, LLC | 775,034 | $1.26M | 0.13% | +632,076+442.1% | Added |
| Almitas Capital LLC | 494,778 | $806.5K | 0.18% | +494,778 | New |
| Renaissance Technologies LLC | 468,598 | $763.8K | 0.00% | +88,798+23.4% | Added |
| Geode Capital Management, LLC | 437,285 | $712.9K | 0.00% | +40,303+10.2% | Added |
| BlackRock, Inc. | 345,461 | $563.1K | 0.00% | +9,723+2.9% | Added |
| HighTower Advisors, LLC | 308,500 | $502.9K | 0.00% | 00.0% | Unchanged |
| Union Square Park Capital Management, LLC | 224,746 | $366.3K | 0.25% | +103,889+86.0% | Added |
| Marshall Wace, LLP | 210,045 | $342.4K | 0.00% | +210,045 | New |
| State Street Corp | 198,111 | $322.9K | 0.00% | +73,200+58.6% | Added |
| Alphabet Inc. | 189,122 | $308.3K | 0.01% | 00.0% | Unchanged |
| Shay Capital LLC | 136,955 | $223.2K | 0.04% | −13,045−8.7% | Reduced |
| Mariner, LLC | 122,461 | $199.6K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 95,122 | $155.0K | 0.00% | −33,495−26.0% | Reduced |
| Scharf Investments, LLC | 91,061 | $148.4K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 88,519 | $144.0K | 0.00% | +88,519 | New |
| Gsa Capital Partners LLP | 87,235 | $142.0K | 0.01% | +53,417+158.0% | Added |
| Northern Trust Corp | 64,706 | $105.5K | 0.00% | −12,786−16.5% | Reduced |
| Citadel Advisors LLC | 56,914 | $92.8K | 0.00% | −36,991−39.4% | Reduced |
| Jane Street Group, LLC | 35,160 | $57.3K | 0.00% | +35,160 | New |
| Operose Advisors LLC | 31,568 | $51.5K | 0.01% | +31,568 | New |
| Group One Trading, L.P. | 30,830 | $50.3K | 0.00% | +30,830 | New |
| Anfield Capital Management, LLC | 30,227 | $49.3K | 0.01% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 15,200 | $25.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 15,080 | $24.6K | 0.00% | −2,306−13.3% | Reduced |
| Nixon Peabody Trust Co | 11,126 | $18.1K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 6,990 | $11.4K | 0.00% | 00.0% | Unchanged |
| Advisory Services Network, LLC | 5,500 | $8.96K | 0.00% | +5,500 | New |
| Morgan Stanley | 3,690 | $6.01K | 0.00% | −612−14.2% | Reduced |
| Bank of America Corp | 2,089 | $3.40K | 0.00% | −815−28.1% | Reduced |
| Tower Research Capital LLC (TRC) | 1,604 | $2.62K | 0.00% | +1,604 | New |
| UBS Group AG | 1,472 | $2.40K | 0.00% | −1,374−48.3% | Reduced |
| Advisor Group Holdings, Inc. | 827 | $1.32K | 0.00% | +550+198.6% | Added |
| JPMorgan Chase & Co | 469 | $764 | 0.00% | 00.0% | Unchanged |
| JDM Financial Group LLC | 340 | $554 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 295 | $481 | 0.00% | 00.0% | Unchanged |
| Hurley Capital, LLC | 121 | $197 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 100 | $163 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 78 | $127 | 0.00% | +1+1.3% | Added |
| Westside Investment Management, Inc. | 75 | $122 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 8 | $13 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 5 | $9 | 0.00% | −18−78.3% | Reduced |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −169,554−100.0% | Sold out |
| Intellectus Partners, LLC | 0 | $0 | 0.00% | −53,312−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −22,660−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,004−100.0% | Sold out |